Product Withdrawals

Known as: Product Withdrawal, Market Withdrawal, Withdrawals, Product 
A removal or correction by manufacturer or owner of a marketed product that the FDA considers to be either no violation or in minor violation of the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1994-2017
02419942017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
After approval, many prescription medications that patients rely on subsequently receive new black-box warnings or are withdrawn… (More)
Is this relevant?
2013
2013
BACKGROUND In October 2007, manufacturers voluntarily withdrew over-the-counter (OTC) infant cough and cold medications (CCMs… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2012
2012
BACKGROUND Human babesiosis in the United States is primarily attributable to infection with the intraerythrocytic protozoan… (More)
Is this relevant?
2012
2012
There have been 13 high-profile product withdrawals in the United States during the past 4 years. These withdrawals have been due… (More)
  • figure 1
  • table 1
  • figure 2
Is this relevant?
2012
2012
BACKGROUND IMAGe provides information on risks and benefits of medication use during pregnancy and lactation. OBJECTIVE The aim… (More)
Is this relevant?
2011
2011
Drug-induced liver injury (DILI) is one of the most common adverse reactions leading to product withdrawal post-marketing… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2011
2011
OBJECTIVE Women who become pregnant during the conduct of biomedical human immunodeficiency virus prevention trials are taken off… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2009
2009
OBJECTIVE To examine effects of the COX-2 inhibitor market withdrawals on NSAID utilization among patients at increased risk of… (More)
Is this relevant?
2009
2009
BACKGROUND Six major pharmaceutical products were withdrawn from the market from 2000 to 2006. Little evidence exists in… (More)
Is this relevant?
2006
2006
OBJECTIVE To examine cyclooxygenase 2 inhibitor (coxib) utilization by rheumatologists for patients receiving nonsteroidal… (More)
Is this relevant?